CM Life Sciences II Inc. Unit
CMIIU
CMIIU was delisted on the 1st of September, 2021.
38 hedge funds and large institutions have $237M invested in CM Life Sciences II Inc. Unit in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 31 closing their positions.
18% less capital invested
Capital invested by funds: $290M → $237M (-$52.9M)
34% less funds holding
Funds holding: 58 → 38 (-20)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
65% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$37.9M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$10.5M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$9.53M |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$7.07M |
| 5 |
HC
Hourglass Capital
Houston,
Texas
|
+$2.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
-$30.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$16M |
| 3 |
PTC
Petrus Trust Company
Dallas,
Texas
|
-$10.2M |
| 4 |
SHCM
Sachem Head Capital Management
New York
|
-$10.2M |
| 5 |
Blackstone Inc
New York
|
-$7.68M |
CMIIU Hedge Fund Activity: Q2 2021 in Review
38 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences II Inc. Unit (CMIIU) for Q2 2021, worth a combined $237M — down 18% from $290M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of CMIIU and 11 opened new positions — a net loss of 20 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was ARK Investment Management, opening a new position worth an estimated $37.9M. The largest seller was SB Management, cutting an estimated $30.9M.
- 38 institutional investors held CM Life Sciences II Inc. Unit (CMIIU) as of Q2 2021, down from 58 in Q1 2021.
- Funds reported $237M of CM Life Sciences II Inc. Unit stock for Q2 2021, down 18% quarter-over-quarter.
- 11 funds opened new CM Life Sciences II Inc. Unit positions in Q2 2021 and 31 closed out, a net change of -20 holders.
- The largest CM Life Sciences II Inc. Unit buyer in Q2 2021 was ARK Investment Management, an estimated $37.9M added.
- The largest CM Life Sciences II Inc. Unit seller in Q2 2021 was SB Management, an estimated $30.9M sold.
Based on aggregated 13F filings for Q2 2021.